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L, INTRQDUCTION 
Biotinylared derivatives of polypeptide hormones 
have proven to be useful tools for studying the interac- 
tion between hormones and their receptors in living 
cells [f-3) and also For purifying hormone receptofs 
with avidin affinity columns [4-g]. Esgceially promis- 
ing are biotinylated derivatives in which the biotin is 
lirlked to the hormone over a spacer arm. Vasoactivc 
intestinal polypeptide (VIP) is a 28-amino acid peptide 
first characterized from porcine duodenum [lo] and 
has been demonstrated to be involved in numerous 
biological events (111, The amino acid sequence of pig 
VIP [ 121 is: His-Ser-Asp-Ala-Val-Pl~e~rhr-Asp-Asn- 
Tyr-Thr,.,Arg-Leu-Arg-Lys’5-Gln-Met-Ala-Val-Lys2a- 
Lys2’-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2. VIP has 
subsequently been isolated from several other species of 
vertebrates. With the exception of guinea-pig VIP all 
mammalian forms, including human, have been found 
to have the same sequence [l 11. Studies of truncated 
peptides suggest hat the biological activity is full) 
preserved only in the intact peptide [131. Calculation by 
Fournier et al. [14] has suggested that an cr-helix do- 
main spans residues 13-28 segregating the sequence in 
an amphiphilic manner. By substituting either the 
hydrophobic or hydrophilic surface it has been sug- 
gested that the hydrophilic surface does not participate 
strongly in receptor binding [ 151. The biotin marker 
can be readily introduced into VlP via the e-amino 
group OF lysinc residues at positions 15, 20 and 21, 
rcsidurs that are hypothesized to be located in the 
hydrophilic ares. The high affinity (& = lo-” M) OF 
biotin for egg white avidin and streptavidin [16] pro- 
vides an important experimental strategy For the 
qualitative and quantitative study of membrane recep- 
tors. In this report WC have tested several biotinyl-e- 
aminocaproylated VIP derivatives as potential 
receptor-avidin cross-linking agents. 
2. MATERIALS AND METHODS 
2. I , Moterids 
VIP was isolntcd from pig intestine as described previously [lOI 
Stllforuccinimidyl.(i-(biotinamido) hcxanoatc (NMSLC-Biotin) war 
from Pierce (Europe BV), endoprotcinasc LysC is a product of 
Boehringer Mnnnhcim (Germany), phcnylmcthylsulfonylfluoridc 
(PMST:) of Merck (Germany), Trir-HCI, bovine serum albumin 
(BSA) Fr.V and bacitracin of Sigma (USA), Placidyl was obtained 
from Abbot (USA), arid (3~[‘251]iodotyrosy110)VIP was obtained 
from Amcrsharn (UK) and is referred to as ““I~VIP. 
2.2. Bioritlyl-e-atriinoca~royla~ion of VIP 
A mixture of 0.9 Fmol VIP and I .2 or 3.6 ,~cmol NHS-LC-Biotin 
was dissolved in 2.5 ml 50 mM N~HCOJ. After 30 min of incubation 
at room temperature the reaction was stopped by the addition of 
0.G ml I M acetic acid and the mixture lyophilired. Separation of the 
reaction products was performed by reversed-phase HPLC on a TSK 
ODS 120-T Cl8 column (7.8 x 300 mm; LKB, Sweden) at a flow rate 
of 1 .S ml/min in O,l% trifluoroacetic acid and a linear gradient of 
30-45% acetonitrile/O.l% TPA in 50 min. Elutcd fractions, named 
BO-B7, were lyophilized and stored at -20°C. 
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2.3. Analysis of biorinyl-c-atninocaproylated VIP-derivatives 
HPLC-purified fractions Hi -i37 (SO-40 @j were digested wiih en- 
doproteinase Lys-C at a substrate-to-enzym- ratio of 25 : 1 (wt/wt) in 
300 hl of 0.1% ammonium bicarbonate ior 4 h at 37°C. After 
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tyaphlliwllon 0~ frautirrrrr war@ nubjesrcd Irx TEmrr~af8lluhr plaJrn# 
db~~p&~n mass spaetrQmorrr tlQW#l Mnp x If9bxi Din 20 ma6f 
ap~lremrrer tRiol0n Nardlc AU, tJpps&, Swdtn), %amplcr w4rr 
dk+J&‘d& in 0,I-Q fFh ceeralning( fORo elhanol, hddd IB 
aiuminlunr fails rsvers$ whir nlrrtrsrllrh3~e rnd rvaporslcd by 8 
stream t3f nirrsgon, Data were 8erlumularcd ft3r IS, mln 81 I5 kV lea 
esicrarlan voltage. ilydqon and sodium were used as imernal sit+ 
dards for crlihratian of the timd data IO rn8% hlalscultrr wei$hrr of 
the fra&menrs In the differem digcrl were ablalncd from rhc Sin le. 
charged 8r daublo-charged proranalcd moleeulc~ /MM”, 1 MI4 “I. 
!%me fragmemo, twprelrlly from the Gterminal pepW! rapian, ww 
also detcfu~l as carlenl8xi nddurl ions (MNa”‘,. Natural VIP and its 
derivarivcr were slmElarly hydralyaed and analyzed by anrlyticel 
HPLC, Vydar Cl8 (218TPS46, 4.6 x 250 mm; The Separations 
Group, Nespcrir, CA, USA) a1 I\ flow WC of I ml/min with a linear 
gradism 0r B-50% in 30 mln tlsinfi the same rolvcms as described 
nbovc. 
Experiments were pcrformrd whh pig crude liver cell membranes 
prepared esrcmlally as described by Couvineau et al, (171. Briefly, 
fresh pip liver was homogen@d wilh a Waring blender In 4 vola 
10 mM triethanolomine pX 7.5, 0.25 M sucrose, 5 mM EDTA and 
0.1 mM PMSF. The t~magenalc was fihcrcd through 2 layers of 
gaurc and cenlrif,grd at 2600 x p for IO min, The rupernatant was 
then fillered through gauze and cemrifu#cd at 4OooO x # for 20 min. 
The resulting pellet was washed twice with 20 mM Tris+iCI, pH 7,1, 
and resuspended in this buffer at a protein eoncenrrwrion of 
25 mg/ml, aliquotcd and stored RI -WC. Protein concentrations 
were measured with the BCA assay (Picrcc:) using BSA as standard. 
Binding experiments were performed 85 previously described [18) 
with some minor modifications. Samples were incubarcd at a protein 
conccnlration of 0.8 mg/ml in 25 mM Tris+lCl, pH 7.S,O.S% USA, 
O.K5 mg/ml bacitracin and 20pM “‘I.VIP in a final volume of 
250&l in the absence or presence of increasing concentrations of 
natural VIP or tiPLC.purified fractions 80-87, Lignnd conccnrra. 
tions wcrc corrected for molecular weight. Nonspecific binding was 
determined in the prcscncc of I pM VIP and represented less than 
10% of total binding. 
The ability of YIP to increase pancreatic bicarbonate juice secre- 
tion in nncsthesizcd (Placidyl) cot was performed as described earlier 
for secretin [ 191. The VIP.derivntives and a reference sample (natural 
porcine VIP) were injected intravenously and pancreatic juice 
secreted from the pancreas was analyzed for alkali content. 
3. RESULTS 
3.1. Biotinyl-s-antinocaproylntion of VIP 
The reaction of porcine VIP with NHS-LC-Biotin 
resulted in a mixture of biotinyl-e-aminocaproylated 
products. These were separated by reversed-phase 
HPLC int,o several discrete components (Fig. 1) 
designated BO-B7. In the order of their elution, BO 
most probably represents he underivatized VIP since it 
elutes in the same position as natural VIP, and Bl-B7, 
all less polar than VIP, the biotinyl-e-amino- 
caproylated erivatives. The reaction performed at a 
1: 1.3 ratio of VIP/NH§-LC-Biotin resulted mainly in a 
production of the components Bl-B3, while a higher 
ratio of NH%LC-Biotin produced relatively more of 
the components B4-B7. 
The possible reaction sites in VIP for NHS-LC- 
Biotin are the reactive amino groups of the 3 lysine 
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pig. I, #PtCqMticarion or bistinyl-r.anrinaeaprorlrled VIP. 
residues and the amino terminal of the pcgtide. In 
order to determine the degree and position of biotinyl- 
e-aminocaproylation i the derivatives, each peptide 
(Bl-B7) was digested with endoptoteinase Lys-C. This 
enzyme cleaves apeptide at the carboxyl side of a lysine 
residue only, and if the lysine is biotinyl-s- 
aminocaproylated cleavage does not occur. Mass spcc- 
tra of each digested pcptidc mixture were recorded and 
the results for Bl, B2 and B3 show m/z peaks cor- 
responding to VIP 21-28., VIP 16-21. and VIP 
1-20.monobiotinyl-a-aminocaproylated respectively 
(Fig. 2 and Table I), B4-B’7 were similarly analyzed 
and the data are consistent with dibiotinyl-e- 
aminocaproylation in B4-B6 and tribiotinyl-e- 
aminocaproylation of B7 (Table II). The Bl-B3 pep- 
tide digests were also analyzed by analytical HPLC and 
the pattern obtained compared to that of enzyme- 
treated natural VIP (Fig, 3). Since biotinyl-s- 
aminocaproylation of a lysine eliminates one potential 
cleavage site one would, in the monobiotinyl-s- 
aminocaproylated erivatives, expect to see both a 
disappearance of 2 (Bl and B2) or 3 (IS) fragments 
relative to the HPLC profile of natural VIP-fragments 
and also the appearance of a new product. The disap- 
pearance of VIP 21-28 and 22-28 in the digest of Bl, 
VIP 16-21 and 16-20 in that of B2, and VIP 1-15, 
16-20 and 16-21 in that of B3 are in agreement with 
the PDMS data and are consistent with biotinylation 
sites of Lys” in Bl, Lys2’ in B2 and Lys” in B3. 
Among the analyzed peptides no biotinyl-s- 
aminocaproylation was observed at the potentially 
reactive amino terminal. 
3.2. Receptor binding properties of bio V.Ps 
Biotinyl-E-aminocaproylated peptides Bl -BY were 
tested for their ability to specifically displace ‘“%-VIP 
Fig. 2. Mass spectra from biotinyl-e-aminocaproylated VIP-derivatives Ftl, B2 and 83 after cndoproteinase LysX treatment. The background 
has been subtracted in all spectra. The peaks corresponding to the various peptides are summarized in Table 1. 
binding to pig liver membrane (Fig. 4). VIP has been 
shown [I71 to bind with high affinity to a single site in 
this tissue. Natural VIP displaced ‘251-VIP-binding ina 
dose-dependent manner with an K&O value of 3.05 1 
0. IS nM. Biotinyl-e-aminocaproylated VIP-peptides 
displaced 12sI-VIP and the order of potency as com- 
pared to VIP is: VIP > B3 > I31 > I32 3 I35 > B4 > 
I% % B7. The I& values of the biotinylated derivatives 
compared to that of natural VIP show that the analogs 
Bl, B2 and B3 are potent VIP-receptor ligands with 
1.3-3.2 times higher ICSO values than VIP and that the 
derivative monobiotinyl-e-aminocaproylated in posi- 
tion Lys” is the most potent ligand (Table II). 
3.3. Biological properties of bio VIPs 
VIP has been shown to stimulate pancreatic juice 
secretion in the anesthetized cat [20]. Monobiotinyl-e- 
aminocaproylated VIP-derivatives gave a rapid VIP- 
like response, similar to that of natural VIP, when 
tested. B3 was the most potent derivative with an 
almost equipotent response as compared to VIP while 
El2 seems to be biotinyl-e-aminocaproylated at the least 
favorable position giving a response Iess than half of 
VIP itself (Pig. 5). The his- and tribiotinyl-e- 
aminocaproylated derivatives also stimulated pan- 
creatic juice secretion but with a decrease in dose 
response following an increase in biotinyl-s- 
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l& vwlucs, rclncivc pelcney and biolinyl~r.aminocrpr~~latrtl 
position(s) of VIP and VLP&rivativcs 
Analog Go Polcllcy Po%ition of biotinyk- 
(nN) aminocsproylalion 
VIP 3*0 P 0.2 ++* 
BI 8.6 t 0.5 + + + 21 
:: 
9.9 f 0.3 c 20 
4.0 ,. 0.2 ++* IS 
B4 27.3 * 7.3 =i.& 20, 21” 
BJ 16,1 * 0.9 ++” is, 21X 
B6 2983 + 3,2 *” IS, 2on 
B7 > 1 /tM (+ s 15, 20, 21R 
’ Data not shown 
ICJO values represent the incan f2 SEM from 2--3 scparatc 
experiments and the potency of VIP~dcrivativcs is compared to VIP 
at the same dose tested. Positions of biotinyl~~.aminocaproylation 
were from mass spectral analysis 
BI B2 
4r 
X 
A- d __A._ 
Retention time (min) 
Fig. 3. HPLC chromatograms of endoproteinasc Lys-C digest of VIP and the biotinyk-aminocaproylated derivatives Bl, B2 and 83, VIP 
fragments were determined after total amino acid determination. (X) denotes the appearance of a new product. 
aminocaproylation umber (data not shown) indicating 
that none of the lysine residues is an absolute require- 
ment for a biological response. 
4. DISCUSSION 
The products of random biotinyl-e-aminocaproyl- 
ation of VIP were characterized by combined MPLC 
and mass spectral analysis that revealed istinct pro- 
ducts of VIP mono-, bis-, or tribiotinyl-s-amino- 
caproylated at lysine residues, The lack of any 
detectable biotinyl-s-aminocaproylation at the amino 
terminal remains unclear but has also been observed in 
the biotinylation of human P-endorphin [21] while a 
parathyroid hormone analog is readily biotinylatcd at 
the N-terminal position [22]. The lower reactivity of the 
amino terminal histidine residue might indicate that 
this residue is involved in forming the folded structure 
of the peptide as has been suggested for VIP [23] and 
for /3-endorphin [24]. The s-amino groups of lysine in 
VIP are readily biotinyl+aminocaproylated producing 
analogs that are recognized by the VIP-receptor in pig 
liver and exert biological activity in the cat pancreas. 
The position of biotinyl-e-aminocaproylation at Lys” 
and Lys21 appears to have less influence on 
VIP-receptor binding as compared to position LyszO. 
Indeed, when the binding affinity of monobiotinyl-e- 
aminocaproylated (Bl, B2, 133) and the bisbiotinyl-e- 
aminocaproylated (B4, B5, B6) are compared separate- 
ly, the higher ICso values obtained are attributed to the 
derivatives biotinylated on Lys2’ (B2, B4, BS). It is in- 
teresting that VIP Bl and B3 both stimulated the cat 
pancreas with a potency only slightly lower than VIP 
itself while B2 showed a clearly lower potency sug- 
gesting that the Lys2’ residue is somewhat more critical 
for binding to the receptor and initiating activity. 
Whether this is a result of lower affinity for the recep- 
tar or an inability to stimulate activation of the second 
messenger carmot be concluded from these results ince 
it has been suggested that heterogeneity exists for VIP- 
binding sites in different tissues [25,26]. The difference 
in binding affinity and biological activity observed can 
be attributed directly to the modification of lysinc 
residues of VIP. However, it cannot be excluded that 
these differences result as a consequence of creating a 
larger lipophilic biotin moiety rather than masking the 
positively charged s-amino group of lytine, 
The most promising derivative for studies of 
VIP-receptor interaction is that in which VIP is 
biotinyl-e-aminocaproylatcd in position Lys”, a part of 
the molecule that seems not to interact with the rccep- 
tor since it has also been shown that Arg” [27] and 
Meti’ [2g] are accessible for modification, The 
biotinylated ligands with a spacer arm of 6 carbons, 
making them more accessible for a high affinity and 
stable interaction with avidin, should be useful for the 
study of receptor-mediated endocytosis using detec- 
table avidin conjugates. Another important use of 
biotinylated anafogs is in the purification of receptor 
protein(s) via avidin-biotin affinity chromatography. 
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